Related references
Note: Only part of the references are listed.Part I: Pituitary adenylate cyclase-activating polypeptide-38 induced migraine-like attacks in patients with and without familial aggregation of migraine
Song Guo et al.
CEPHALALGIA (2017)
Intact blood-brain barrier during spontaneous attacks of migraine without aura: a 3T DCE-MRI study
F. M. Amin et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
Increased brainstem perfusion, but no blood-brain barrier disruption, during attacks of migraine with aura
Anders Hougaard et al.
BRAIN (2017)
Change in brain network connectivity during PACAP38-induced migraine attacks A resting-state functional MRI study
Faisal Mohammad Amin et al.
NEUROLOGY (2016)
Premonitory and nonheadache symptoms induced by CGRP and PACAP38 in patients with migraine
Song Guo et al.
PAIN (2016)
Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks
Farooq Husain Maniyar et al.
BRAIN (2014)
Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38
Faisal Mohammad Amin et al.
BRAIN (2014)
Comparison of responses to vasoactive drugs in human and rat cerebral arteries using myography and pressurized cerebral artery method
Gustaf Grande et al.
CEPHALALGIA (2013)
Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR Review 1
Anthony J. Harmar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers
Faisal Mohammad Amin et al.
CEPHALALGIA (2012)
The TAT peptide endows PACAP with an enhanced ability to traverse bio-barriers
Rongjie Yu et al.
NEUROSCIENCE LETTERS (2012)
Intranasal administration of PACAP: Uptake by brain and regional brain targeting with cyclodextrins
Naoko Nonaka et al.
PEPTIDES (2012)
Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery
Kayi Y. Chan et al.
CEPHALALGIA (2011)
Matrix metalloproteinases during and outside of migraine attacks without aura
M. Ashina et al.
CEPHALALGIA (2010)
The PACAP Receptor: A Novel Target for Migraine Treatment
Henrik W. Schytz et al.
NEUROTHERAPEUTICS (2010)
PACAP38 induces migraine-like attacks in patients with migraine without aura
Henrik Winther Schytz et al.
BRAIN (2009)
Isolation of peptide transport system-6 from brain endothelial cells: therapeutic effects with antisense inhibition in Alzheimer and stroke models
Dilek Dogrukol-Ak et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
D. Vaudry et al.
PHARMACOLOGICAL REVIEWS (2009)
Effect of lipopolysaccharide on the transport of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier
N Nonaka et al.
EXPERIMENTAL NEUROLOGY (2005)
Passage of VIP/PACAP/secretin family across the blood-brain barrier: Therapeutic effects
D Dogrukol-Ak et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Regional differences in PACAP transport across the blood-brain barrier in mice:: a possible influence of strain, amyloid β protein, and age
N Nonaka et al.
PEPTIDES (2002)
Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia
M Knutsson et al.
NEUROREPORT (2002)
Effect of middle cerebral artery occlusion on the passage of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier in the rat
A Somogyvári-Vigh et al.
REGULATORY PEPTIDES (2000)
Share Paper
